Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis

Pediatrics

Volumn 106, Issue 2 I, 2000, Pages 367-376

  Overturf, G D ^a   Peter, G ^a   Pickering, L K ^a   MacDonald, N E ^a   Chilton, L ^a   Jacobs, R F ^a   Delage, G ^a   Dowell, S F ^a   Orenstein, W A ^a   Patriarca, P A ^a   Myers, M G ^a   Ledbetter, E O ^a   Kim, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; PENICILLIN V POTASSIUM; PNEUMOCOCCUS VACCINE; BACTERIAL VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCUS VACCINE; VACCINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBODY RESPONSE; ARTICLE; ASPLENIA; CHILD; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EDEMA; ETHNIC GROUP; FEVER; FOOD AND DRUG ADMINISTRATION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION PREVENTION; INFECTION RATE; INJECTION PAIN; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STREPTOCOCCUS INFECTION; IMMUNOLOGY; INFANT; OPPORTUNISTIC INFECTION; RISK FACTOR; TREATMENT OUTCOME;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL VACCINES; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MENINGOCOCCAL VACCINES; OPPORTUNISTIC INFECTIONS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; TREATMENT OUTCOME; VACCINES, CONJUGATE;

EID: 0034241677     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.106.2.367     Document Type: Article

References (73)

1. Recommendations for using pneumococcal vaccine in children
2. Pneumococcal infections
3. Therapy for children with invasive pneumococcal infections
4. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practice (ACIP)
5. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia
6. Bacterial meningitis in the United States in 1995
7. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens
8. Pneumonia in pediatric outpatients: Cause and clinical manifestations
9. Etiology of childhood pneumonia: Serologic results of a prospective, population-based study
10. The management of pneumonia in children in developing countries
11. Microbiology of empyema in children and adolescents
12. Sinusitis in children
13. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
14. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective, cohort study
15. Bacterial meningitis and septicemia in sickle cell disease
16. Fatal pneumococcal septicemia in hemoglobin SC disease
17. Bacteremia in sickle hemoglobinopathies
18. Infections and immunizations of children with sickle cell disease
19. Septicemia and meningitis in children splenectomized for Hodgkin's disease
20. Infection associated with asplenia: Risks, mechanisms and prevention
21. Sepsis and congenital asplenia
22. Bacterial infection in the acquired immunodeficiency syndrome of children
23. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1
24. Invasive pneumococcal infections in human immunodeficiency virus-infected children
25. Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection
26. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population
27. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990: Ethnic differences and opportunities for prevention
28. Risk factors for primary invasive pneumococcal disease among children in Finland
29. Upper respiratory tract infections in young children: Duration of and frequency of complications
30. Frequency and severity of infections in day care
31. Risk factors for invasive pneumococcal disease in children: A population-based case-control study in North America
32. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Tex, day-care center
33. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio
34. A cluster of invasive pneumococcal disease in young children in child care
35. Carriage of multidrug-resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center
36. Hemorrhage and shock associated with invasive pneumococcal infection in healthy infants and children: New Mexico 1993-1994
37. Colonization with penicillin-resistant Streptococcus pneumoniae in a child day-care center
38. Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centers
39. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel
40. Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area
41. Serotypes of respiratory isolates of Streptococcus pneumoniae compared with the capsular types included in the current pneumococcal vaccine
42. Potential interventions for the prevention of childhood pneumonia: Geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children: Implications for vaccine strategies
43. Assessment of the pneumococcal polysaccharide vaccine. IV. Efficacy of pneumococcal vaccine in infants and children
44. Pneumococcal conjugate vaccines
45. Pneumococcal disease after pneumococcal vaccination: An alternative method to estimate the efficacy of pneumococcal vaccine
46. Efficacy of pneumococcal vaccination against recurrent otitis media: Preliminary results of a field trial in Finland
47. Vaccination against Streptococcus pneumoniae in childhood: Lack of demonstrable benefit in young Australian children
48. Pneumococcal infections in splenectomized children are preventable
49. Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease
50. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children
51. Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid
52. 197 in United States infants
53. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: Implications for development of a conjugate vaccine
54. 197 conjugate vaccine in infants and toddlers
55. Minimum protective serum concentrations of pneumococcal anticapsular antibodies in infant rats
56. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines
57. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
58. 197 on nasopharyngeal carriage of vaccine type and non-vaccine type S pneumoniae strains among day care attendees
59. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
60. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease
61. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: Results from a randomized trial
62. Safety and immunogenicity of three doses of a five valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection
63. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children
64. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial
65. Prevention of pneumococcal infection in children with homozygous sickle cell disease
66. Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia
67. Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia
68. Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease
69. Pneumococcal colonization in children with sickle cell disease
70. Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease
71. Discontinuing penicillin prophylaxis in children with sickle cell anemia: Prophylactic Penicillin Study II